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Voltage-gated calcium channels are the primary mediators of depolarization-induced calcium entry into
neurons. There is great diversity of calcium channel subtypes due to multiple genes that encode calcium
channel a1 subunits, coassembly with a variety of ancillary calcium channel subunits, and alternative
splicing. This allows these channels to fulfill highly specialized roles in specific neuronal subtypes and at
particular subcellular loci. While calcium channels are of critical importance to brain function, their inappro-
priate expression or dysfunction gives rise to a variety of neurological disorders, including, pain, epilepsy,
migraine, and ataxia. This Review discusses salient aspects of voltage-gated calcium channel function,
physiology, and pathophysiology.Introduction
The electrical activity of neurons and other excitable cells relies
on a number of different types of voltage- and ligand-gated ion
channels that are permeable to inorganic ions such as sodium,
potassium, chloride, and calcium. While the former three ions
support a predominantly electrogenic role, calcium ions are
different in that they can not only alter membrane potential
but also serve as important signaling entities (Clapham, 2007).
Under normal resting conditions, intracellular calcium con-
centrations lie in the 100 nM range due to calcium-buffering
molecules and sequestration into intracellular calcium stores
(Clapham, 2007). Opening of voltage-gated calcium channels
results in calcium influx along the electrochemical gradient,
thus giving rise to a localized elevation of intracellular calcium
into the high micromolar range (Wadel et al., 2007). This in
turn triggers a wide range of calcium-dependent processes
that include gene transcription, neurotransmitter release, neu-
rite outgrowth, and the activation of calcium-dependent
enzymes, such as calmodulin-dependent protein kinase II
(CaMKII) and protein kinase C (PKC) (Wheeler et al., 1994,
2008, 2012) (for review, see Clapham, 2007). On the other
hand, prolonged elevation of intracellular calcium levels is cyto-
toxic (Stanika et al., 2012) and, as a result, the activities of
voltage-gated and other types of calcium-permeable channels
are tightly regulated both by intrinsic gating processes, as well
as by cell signaling pathways that control channel activity and
trafficking to and from the plasma membrane (Simms and
Zamponi, 2012). Dysregulation of these processes and asso-
ciated alterations in calcium channel activity have been linked
to various types of neurological disorders, including epilepsy,
migraine, and chronic pain (for review, see Cain and Snutch,
2011). Therefore, voltage-gated calcium channels are important
pharmacological targets for these and other conditions (Belar-
detti and Zamponi, 2012). Here, we will provide an overview
of the physiological and pathophysiological roles of voltage-
gated calcium channels in the central and peripheral nervous
systems and highlight selected aspects of their structure, func-
tion, and modulation.24 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.Subtypes, Pharmacology, and Structure of Voltage-
Gated Calcium Channels
Voltage-gated calcium channels fall into two major categories:
high voltage-activated (HVA) channels that open in response to
large membrane depolarizations and low voltage-activated
(LVA) channels that are activated by smaller voltage changes
(Armstrong and Matteson, 1985; Bean, 1985) near typical
neuronal resting membrane potentials. Based on biochemical
and molecular analyses (Curtis and Catterall, 1984), we now
know that HVA channels are heteromultimeric protein com-
plexes that are formed through the coassembly of a pore-form-
ing Cava1 subunit, plus ancillary Cavb and Cava2d subunits,
whereas LVA channels appear to lack these ancillary subunits
(Catterall et al., 2005). The Cava1 subunit is the key determinant
of calcium channel subtype. There are three major families of
Cava1 subunits (termed Cav1, Cav2, and Cav3), each of which
have several members (Catterall et al., 2005). The Cav1 channel
family encodes three different neuronal L-type channels (termed
Cav1.2, Cav1.3, and Cav1.4) plus a skeletal muscle-specific
isoform, Cav1.1 (Bech-Hansen et al., 1998; Mikami et al., 1989;
Tanabe et al., 1987; Williams et al., 1992b). These channels
display slow voltage-dependent gating characteristics and are
sensitive to a number of different dihydropyridine (DHP) antago-
nists and agonists (Randall and Tsien, 1995). The Cav2 channel
family includes three members (Cav2.1, Cav2.2, and Cav2.3).
Through alternative splicing and assembly with specific ancillary
subunits, Cav2.1 gives rise to P- and Q-type channels (Bourinet
et al., 1999; Richards et al., 2007), which are both blocked (albeit
with different affinities) by u-agatoxin IVA—a peptide isolated
from American funnel web spider venom (Adams et al., 1993).
Cav2.2 encodes N-type channels (Dubel et al., 1992; Williams
et al., 1992a) that are selectively inhibited by u-conotoxins
GVIA and MVIIA, toxins isolated from the venom of marine
fish-hunting mollusks Conus geographus and Conus magus,
respectively (McCleskey et al., 1987; Olivera et al., 1987).
Cav2.3 corresponds to R-type channels (Soong et al., 1993)
that can be inhibited by SNX-482, a peptide from Hyristocrates
Gigas Tarantula venom (Bourinet et al., 2001; Newcomb et al.,
Figure 1. Subunit Composition and
Transmembrane Topology of Voltage-
Gated Calcium Channel Subunits
HVA channels are heteromultimers comprised of a
pore-forming Cava1 subunit that coassembles
with ancillary Cavb, Cava2d, and possibly Cavg
subunits, plus calmodulin (CaM); LVA channels on
the other hand function as Cava1 subunit mono-
mers. The Cava1 subunit is comprised of four
major transmembrane domains (I–IV) that are
connected by cytoplasmic linkers. Each of these
domains contains six membrane-spanning heli-
ces, plus a re-entrant pore loop (shown in green).
The fourth transmembrane segment in each
domain contains positively charged amino acids in
every third position and forms the voltage sensor.
Key protein interaction sites with the Cava1 sub-
units are indicated by numbers: (1) N-terminal
calmodulin association site in L-type channels, (2)
Cavb interaction domain in all HVA channels, (3)
synaptic protein interaction site (synprint) present
in Cav2 channels, (4) PreIQ-IQ and IQ motifs in
Cav1 and Cav2 channels that associate with
calmodulin, and (5) scaffolding protein interaction
sites in Cav2 channels. The Cava2d subunit is
attached to the extracellular leaflet of the plasma
membrane via a GPI anchor. The Cavb subunit
contains conserved interacting GK and SH3 do-
mains that are separated by regions that are more
variable among different Cavb subunit isoforms.
The Cavg subunit contains four membrane-span-
ning helices; CaM has been omitted for simplicity.
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and Cav3.3), all of which represent T-type calcium channels
(Cribbs et al., 1998; Lee et al., 1999b; Perez-Reyes et al.,
1998). Cav3 channels can be distinguished by their sensitivity
to nickel and relative resistance to block by cadmium ions, which
block all HVA channels in the low micromolar range (for review,
see Perez-Reyes, 2003).
All ten Cava1 subunits share a common transmembrane
topology of four major transmembrane domains, each of which
contain six membrane-spanning helices (termed S1–S6), a
positively charged S4 segment that controls voltage-dependent
activation (Catterall, 2010), and a re-entrant P loop motif
between S5 and S6 that forms the permeation pathway
(Figure 1). Each of the P loop regions contains highly conserved
negatively charged amino acid residues (in the case of HVA
channels, glutamic acids) that cooperate to form a pore that is
highly selective for permeant cations such as calcium (Ellinor
et al., 1995; Tang et al., 2014; Yang et al., 1993), barium, and
strontium (Bourinet et al., 1996) and that interact with non-
permeant divalents such as cadmium (Lansman et al., 1986).
Different types of calcium channels display different single-
channel conductances that vary over one order of magnitude,
with Cav1.4 channels showing the smallest conductance (Doer-
ing et al., 2005; Fox et al., 1987; Weber et al., 2010). The major
membrane domains are connected by large cytoplasmic linker
regions and are bracketed by cytoplasmic N and C termini (Cat-
terall et al., 2005). These cytoplasmic regions show the greatest
sequence variation among channel subtypes and not only are
important for second messenger regulation of channel function
but also contain important sites for protein-protein interactions
with regulatory elements, such as G proteins and protein kinases
(Dai et al., 2009; Hall et al., 2013; Zamponi et al., 1997). Each ofthe known Cava1 subunits can undergo alternative splicing,
which may occur in a tissue- and age-dependent manner
(Chaudhuri et al., 2004; Liao et al., 2005; Lipscombe, 2005;
Lipscombe et al., 2013; Tan et al., 2011, 2012). Furthermore,
RNA editing has been reported for Cav1.3 channels (Bazzazi
et al., 2013; Huang et al., 2012), thus giving rise to additional
functional diversity.
There are four known genes that encode Cavb subunits
(Cavb1–Cavb4), again with multiple alternative splice transcripts
(for review, see Buraei and Yang, 2010). They are cytoplasmic
proteins that contain conserved GK and SH3 domains and asso-
ciate with the Cava1 subunit at the domain I-II linker (Opatowsky
et al., 2004; Pragnell et al., 1994; Van Petegem et al., 2004)
(Figure 1). This results in alterations of the gating properties of
the Cava1 subunit, and perhaps more importantly, in increased
cell surface trafficking (Brice and Dolphin, 1999; Buraei and
Yang, 2010). The latter phenomenon is due to an inhibition of
ubiquitination and degradation of the channels in the protea-
some and perhaps in part due to masking of intrinsic ER reten-
tion signals in the Cava1 subunit (Altier et al., 2011; Bichet
et al., 2000; Waithe et al., 2011). In addition, it has been sug-
gested that the Cav1.2 domain I-II linker contains an ER export
signal that facilitates membrane expression (Fang and Colecraft,
2011) and that the Cavb subunits act as a switch that shifts
the balance between the export mechanism and ER retention
signals in other parts of the channel, such as the C terminus
(Altier et al., 2011).
There are also four different types of Cava2d subunits
(Cava2d1–Cava2d4) that are each transcribed and translated
as a single protein, posttranslationally cleaved, and then recon-
nected by a disulfide bond (for review, see Dolphin, 2013). It was
originally thought that the Cavd portion spanned the plasmaNeuron 82, April 2, 2014 ª2014 Elsevier Inc. 25
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Cava2d subunit is attached to the extracellular leaflet of the
plasma membrane via a glycophosphatidylinositol (GPI) anchor
(Davies et al., 2010; Kadurin et al., 2012) (Figure 1). While there
appears to be only a small effect of Cava2d on channel function
(Yasuda et al., 2004), its coexpression typically results in
augmented channel cell surface density. These changes in
channel cell surface density are critically dependent on a metal
ion binding site located within a von Willebrand factor domain
of the a2 portion of this subunit (Cantı´ et al., 2005). In neurons,
increased expression of Cava2d results in improved synaptic
targeting of voltage-gated calcium channels and enhanced
release probability, which occurs independently of the trafficking
effect (Hoppa et al., 2012). Recent evidence indicates that
Cava2d subunits act as thrombospondin receptors and it is
possible that interactions with thrombospondin are involved
in the aforementioned modulation of synaptic release (Eroglu
et al., 2009).
Skeletal muscle L-type channels also contain an ancillary
Cavg subunit that contains four transmembrane helices (Arikkath
and Campbell, 2003; Sharp and Campbell, 1989). As many as
seven potential Cavg isoforms have been identified in neuronal
tissue, including Cavg2, which is also known as ‘‘stargazin’’
(Chen et al., 2007; Chu et al., 2001). However, while certain types
of Cavg subunits can have profound effects on whole-cell
current density, it is not clear whether they should be considered
true neuronal calcium channels subunits (Letts et al., 1998;
Rousset et al., 2001). Moreover, subunits such as stargazin
have been associated with other cellular functions such as
AMPA receptor trafficking (Bats et al., 2007; Matsuda et al.,
2013; Tomita et al., 2005). There is however considerable
evidence that all HVA channels associate with calmodulin
(CaM), suggesting that CaM should be considered as the fourth
calcium channel subunit (Minor and Findeisen, 2010; Peterson
et al., 1999; Zu¨hlke et al., 1999). Given the importance of ancillary
subunits for HVA channels, it is surprising that the trafficking and
overall biophysical properties of Cav3 channels in heterologous
expression systems are reconstituted well with only the Cava1
subunit (Perez-Reyes, 2003). Whether T-type channels include
specific membrane-targeting motifs that are absent in HVA
channels or lack ER retention and proteasomal-targeting motifs
remains to be determined.
The majority of the structure/function information about
voltage-gated calcium channels has been deduced from site-
directed mutagenesis and generation of chimeric calcium
channel subunits. Based on the crystal structures of potassium
channels, several homology models of Cava1 subunits have
been constructed and used to model drug interactions, in partic-
ular with L-type channels (Huber et al., 2000; Lipkind and
Fozzard, 2003; Zamponi et al., 2003). Cryo-EM structures have
revealed crude structural information about this channel subtype
(Serysheva et al., 2002; Walsh et al., 2009a, 2009b; Wolf et al.,
2003), however, not at a resolution high enough to gain insights
into the structural basis of channel function. Unlike potassium
and bacterial sodium channels, it has not yet been possible to
obtain crystal structure information concerning entire mamma-
lian Cava1 subunits. Crystal structures of the Cavb subunit
bound to a fragment of the Cava1 subunit I-II linker have been26 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.solved by multiple groups, however (Chen et al., 2004; Opatow-
sky et al., 2004; Van Petegem et al., 2004). Furthermore, cocrys-
tal structure studies and even NMR structures of calmodulin
bound to Cav1.2 and Cav2.1 have been reported (Fallon et al.,
2005, 2009; Kim et al., 2008, 2010; Liu and Vogel, 2012; Mori
et al., 2008; Van Petegem et al., 2005). While these works have
provided some advance in our understanding of subunit regula-
tion of voltage-gated calcium channels, it remains to be deter-
mined whether the observed interactions are relevant to actual
conformations in holochannels or perhaps modified by the pres-
ence of transmembrane regions and other intracellular domains.
Determinants of Calcium Channel Inactivation
To prevent calcium overload in response to prolonged mem-
brane depolarization, voltage-gated calcium channels possess
voltage- and/or calcium-dependent inactivation mechanisms.
Voltage-dependent inactivation (VDI) is a property that is com-
mon to all voltage-gated calcium channel subtypes, although
the extent of voltage-dependent inactivation varies with calcium
channel isoform and is potently modulated in HVA channels by
the Cavb subunit (for review, see Stotz et al., 2004). Unlike
voltage-gated potassium and sodium channels where there is
evidence of a pore blocking, inactivation gating particle for
N-type inactivation mechanisms (i.e., ‘‘ball and chain’’ and
‘‘hinged-lid’’) (Hoshi et al., 1990; West et al., 1992), it has proven
somewhat more difficult to identify the mechanistic basis of VDI
in calcium channels. Numerous studies have identified amino
acid residues that appear to modulate inactivation, and many
of them are found in either the domain I-II linker region or in the
S6 regions of the major transmembrane domains (Berrou et al.,
2001; Herlitze et al., 1997; Kraus et al., 1998; Stotz and Zamponi,
2001a). Based on extensive mutagenesis and chimeric work on
HVA channels (Spaetgens and Zamponi, 1999; Stotz et al., 2000;
Stotz and Zamponi, 2001b), we proposed a model in which the
S6 segments undergo structural rearrangement in response to
prolonged membrane depolarization (Figure 2). This then may
expose a docking site for the domain I-II linker to act as a
hinged-lid-like gating particle (Stotz et al., 2004). In Cav1.3
channels, this docking process may be modulated by an addi-
tional inhibitory element, termed the inactivation shield (Tadross
et al., 2010). Interestingly, Cav3 (T-type) channels appear to be
different from HVA channels with regard to VDI, such that the
domain III-IV linker and C terminus appear to be important struc-
tural determinants in this channel family (Hamid et al., 2006;
Ohkubo et al., 2005; Staes et al., 2001). It is thus possible that
Cav3 channels contain a domain III-IV linker inactivation particle
analogous to what is seen with sodium channel VDI. Whether
these channels also contain an inactivation shield remains to
be determined. Ultimately, crystal structure information will be
required to gain precise insights into how calcium channels inac-
tivate in response to voltage. Understanding how inactivation
works at the molecular level is particularly important given that
many clinically used drug compounds, such as DHPs and anti-
epileptics, show strong inactivated state dependences of block
(Berjukow et al., 2000; Gomora et al., 2001).
A much more complete picture has emerged in the area of
calcium-dependent inactivation (CDI), although it is by nomeans
less complicated. CDI becomes apparent when comparing
Figure 2. Schematic Representation of
Possible Voltage-Dependent Inactivation and
Calcium-Dependent Inactivation
Mechanisms in HVA Channels
(A) Left: membrane depolarizations trigger a
conformational change in the channel that results in
a transition from closed to open (i.e., calcium-con-
ducting state). Prolonged membrane depolarization
triggers a further change in channel conformation
(potentially mediated by the S6 segments in the four
membrane domains, not shown). This may reposi-
tion a channel structure termed an ‘‘inactivation
shield’’ (yellow), thus exposing a docking site for the
inactivation gate that is formed by the domain I-II
linker (blue ball-like structure). The inactivation gate
then physically obstructs calcium entry. Right:
calcium influx upon membrane depolarization also
created a calcium domain near the inner mouth of
the pore. Calcium binds to calmodulin (CaM, indi-
cated by dumbbell structure in red with its high- [H]
affinity and low- [L] affinity calcium binding sites) that
is preassociated with the C terminus of the channel,
which in turn causes molecular repositioning of
CaM in the C terminus region and additional in-
teractions with sites in the N terminus region of the
channel when fully loaded with calcium (small or-
ange dots). This leads to an inactivated (noncon-
ducting) conformation of the channel.
(B) Calcium influx though an individual Cav1 chan-
nels creates a calcium nanodomain that is sufficient
to activate the high-affinity sites on calmodulin, which in turn goes on to cause CDI (this process is EGTA insensitive). In contrast, for Cav2 channels, a concerted
opening of multiple channels gives rise to a calciummicrodomain that activates the low-affinity binding sites of CaM to trigger CDI (this can be blocked by EGTA).
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calcium, with the latter charge carrier imparting pronounced
speeding of current decay kinetics (Imredy and Yue, 1994).
This effect is critically dependent on CaM and blocked by over-
expressing a dominant-negative mutant of CaM that lacks the
ability to bind calcium (Lee et al., 1999a; Peterson et al., 1999;
Zu¨hlke et al., 1999). From amechanistic standpoint, it is believed
that calcium-free CaM is preassociated or anchored to the C
terminus of the channel such that the C-terminal lobe of CaM
interacts with the ‘‘IQ’’ domain and the N-terminal lobe with an
upstream EF-hand region (Ben Johny et al., 2013; Liu et al.,
2010) (Figure 2). Upon a rise in intracellular calcium, channel-
anchored CaM binds calcium, which in turn promotes a confor-
mational change in the C terminus/CaM complex and gives rise
to CDI (Ben Johny et al., 2013; Erickson et al., 2001, 2003; Peter-
son et al., 2000) (Figure 2). For many years CDI was thought to
only occur with L-type channels because no calcium-induced
speeding of current decay kinetics was observed with native or
cloned N-, R-, or T-type channels. However, whole-cell record-
ings during this era were typically performed with 10 mM EGTA
in the patch pipette, which produces significant reduction in
intracellular calcium. On the other hand, when intracellular
calcium buffering is made less stringent with 0.5 mM EGTA,
CDI also becomes apparent for the three members of the Cav2
channel family (Liang et al., 2003). In other words, CDI of
Cav1.2 and Cav1.3 channels is supported by a local rise in
calcium near the inner mouth of the pore, or rather, calcium entry
through an individual channel is sufficient to mediate its own CDI
(Zamponi, 2003a). In contrast, CDI of Cav2 channels requires a
global rise in intracellular calcium, which is supported by the
concerted calcium influx of a population of channels, hence
explaining the EGTA sensitivity of this process (Dick et al.,2008; Erickson et al., 2003; Tadross et al., 2008; Zamponi,
2003a). This differential sensitivity to local and global calcium
rises is due to the differential involvement of the high- and low-
affinity calciumbinding lobes on the CaMmolecule, respectively,
as revealed by site-directed mutagenesis of the calcium binding
sites on CaM.
There are several additional twists to CDI: first, although
Cav1.4 channels can bind calmodulin, they lack CDI (McRory
et al., 2004), the latter because of an autoinhibitory domain in
the distal C terminus that occludes upstream CaM binding
sequences (Griessmeier et al., 2009; Singh et al., 2006; Wahl-
Schott et al., 2006). From a mechanistic point of view, this auto-
inhibitory domain appears to act like an enzyme competitive
inhibitor that regulates the affinity of calcium-free calmodulin
for the channel (Liu et al., 2010). The resulting resistance to inac-
tivation is probably necessary because these channels support
tonic glutamate release in photoreceptor synapses (Morgans,
2000) and must therefore show sustained activity at depolarized
potentials. Second, there is a curious absence of CDI for native
Cav1.3 currents in auditory hair cells. This absence appears to
be due to calcium-binding protein 4 (CaBP4), a CaM homolog
with reduced calcium binding ability that is expressed in these
cells and antagonizes the CDI process (Yang et al., 2006). It
was originally suggested, based on studies on channel frag-
ments, that competition between CaBP4 and CaM for the C
terminus of Cav1.2 may lay at the root of the disruption of CDI
by CaBP (Findeisen et al., 2013; Oz et al., 2013). However,
more recent evidence based onwork in intact channels indicates
that CaBP may modulate CaM affinity by an allosteric mecha-
nism (Yang et al., 2014). Third, recent evidence shows that CDI
of Cav1.2 channels requires two different CaMmolecules bound
to the C terminus (Kim et al., 2010). Fourth, Cav1.3 showsNeuron 82, April 2, 2014 ª2014 Elsevier Inc. 27
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(C-lobe) and low- (N-lobe) affinity calcium binding sites of CaM
(Ben Johny et al., 2013). Cav1 channel CDI that depends on
the high-affinity C-lobe of CaM appears to require only C-termi-
nal regions of the channel, while low-affinity N-lobe CDI involves
interactions of CaM with several N-terminal regions, as well as
the C terminus (Dick et al., 2008; Simms et al., 2013) (Figure 2).
Fifth, crystal structure information reveals that CaM interacts
with the Cav2.1 C terminus in an opposite orientation compared
to Cav1.2 (Kim et al., 2008), whereas Cav2.3 and Cav2.1 seem to
bind CaM in the same orientation (Mori et al., 2008). The physio-
logical significance of this finding is unclear.
Finally, Cav2.1 channels show a second form of calcium regu-
lation (calcium-dependent facilitation [CDF]) that involves the
high-affinity sites on CaM (DeMaria et al., 2001; Lee et al.,
2003). Single-channel recording demonstrates that unlike CDI
of these channels, which requires global calcium increase, cal-
cium entry through an individual Cav2.1 channel is sufficient to
promote CDF (Chaudhuri et al., 2007). Furthermore, this example
highlights howCav2.1 channels can be differentially regulated by
two opposing calcium-dependent processes while using the
same calcium sensor, CaM. Interestingly, L-type channels can
exhibit CDF but only with substantial C-terminal mutations in
the same region that natively promotes CDF of Cav2 channels
(Hudmon et al., 2005; Zu¨hlke et al., 1999) and appears to be
stronger for channels expressed in oocytes compared to
mammalian cells. Whether CDF andCDI aremediated by distinct
binding conformations, orientations of CaM, or separate CaM
molecules bound at different regions of Cav1 and Cav2 channels
remains to be determined.
Altogether, CDI and VDI are important processes that limit
excessive calcium entry into the cytosol. While VDI is intrinsic
to the channel and only depends on voltage, CDI is a tunable
process that provides feedback inhibition in response to rising
intracellular calcium levels.
Role of Voltage-Gated Calcium Channels in Synaptic
Transmission
Voltage-gated calcium channels are important mediators of
depolarization-evoked release of neurotransmitters. To ensure
efficient coupling of calcium influx to rapid vesicle release,
calcium channels must be localized within the active zones of
presynaptic nerve terminals. Most CNS synapses rely on
Cav2.2 and Cav2.1 calcium channels for fast synaptic transmis-
sion (Wheeler et al., 1994) and both of these channel subtypes
contain a synaptic protein interaction (synprint) site within the
intracellular domain II-III linker region. This synprint site interacts
with proteins of the synaptic vesicle release complex, such as
syntaxin 1 and SNAP-25, thus placing the channels in close
proximity to synaptic vesicles (Rettig et al., 1996; Sheng et al.,
1994, 1996). Interaction of the vesicle release complex with
the channels alters calcium channel function by promoting
voltage-dependent inactivation and Gbg modulation (Bezproz-
vanny et al., 1995; Jarvis and Zamponi, 2001). Cav2.3 channels
are also capable of interacting with synaptic vesicle release
proteins, however, with different channel and syntaxin structural
determinants (Davies et al., 2011). The interactions between
Cav2 channels and SNARE proteins have been subject to28 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.numerous reviews (Weiss and Zamponi, 2012; Zamponi,
2003b) and, hence, we will not further belabor the molecular
details. It is however interesting to note that invertebrate Cav2
channels do not possess a synprint-like motif (Spafford et al.,
2003), and splice isoforms of mammalian Cav2.2 and Cav2.1
channels that lack the synprint have been reported (Kaneko
et al., 2002; Rajapaksha et al., 2008). Hence, it appears as if there
are redundant or perhaps more important mechanisms that
localize Cav2 channels to presynaptic sites. Indeed, adaptor
proteins such asMint-1 andCASK (Maximov andBezprozvanny,
2002; Spafford et al., 2003), Rab3-interacting molecules (RIMs)
(Graf et al., 2012; Kaeser et al., 2011; Kiyonaka et al., 2007),
and RIM binding proteins such as DRBP (Liu et al., 2011) all
are important for organizing Cav2 channels within active zones.
Whether this is mediated through direct binding of these proteins
to the Cav2 channel has, however, been subject to some debate
(Wong and Stanley, 2010).
At the majority of CNS synapses, Cav1 channels are localized
postsynaptically rather than presynaptically (Tippens et al.,
2008) and may be anchored to postsynaptic sites via adaptor
proteins such as Shank (Zhang et al., 2005). Cav1.3 and
Cav1.4 channels are, however, important players on the presyn-
aptic side of ribbon synapses in cochlear hair cells and in photo-
receptor terminals (Striessnig, 2013), where their functions are
modulated by other interacting proteins such as CaBP4 (Haesel-
eer et al., 2004). Unlike the Cav2 family, Cav1 channels do not
possess a synprint-like motif for interactions with SNARE
proteins, and they lack theMint-1 andCASK interaction domains
present in Cav2 channels. Instead, the organization of Cav1
channels in these synapses is critically dependent on bassoon
(Frank et al., 2010; Jing et al., 2013). This different molecular
organization may reflect the fact that the requirement for calcium
channel function in postsynaptic photoreceptor nerve termini
compared with, for example, a presynatpic cortical synapse,
are fundamentally different. In the latter case, calcium channels
need to open transiently in response to an incoming action
potential to generate a large but temporally precise calcium
influx, for which N-type channels with their high single-channel
conductance are particularly well suited (Weber et al., 2010). In
contrast, photoreceptors are depolarized in the dark where
they tonically release glutamate (Morgans, 2000), requiring
sustained calcium channel activity that is terminated upon
light-induced membrane hyperpolarization. Not only does this
require calcium channels to be noninactivating (as ensured by
autoinhibitory elements and interactions with calcium binding
proteins, see preceding section), but it may also demand a
completely different architecture of calcium channels and
associated synaptic, anchoring proteins. This underscores the
importance for mammalian neurons to have a palette of different
calcium channels and interacting partners that are tailored for
specific neurophysiological functions.
L-type calcium channels are also important in hormone secre-
tion. This has been particularly well studied in adrenal chromaffin
cells where calcium entry via Cav1.2 and Cav1.3 drives much of
the release of catecholamines (for review, see Vandael et al.,
2013). An interesting twist to the role of calcium channels in
secretion has been observed in these cells (Hagalili et al.,
2008). Hagalili and colleagues reported that Cav1.2 channel
Figure 3. T-type Channel-Mediated
Regulation of Neuronal Excitability
(A) Schematic representation of steady-state
activation and inactivation curves for a T-type
calcium channel. Note the overlap between these
two curves that gives rise to a ‘‘window current’’
(indicated in blue). Note also that the exact posi-
tion of the window current depends on neuronal
subtype. At a typical neuronal resting potential of
70 mV, a large fraction of T-type channels are
inactivated and thus unavailable for opening. A
transient hyperpolarization will recover these
channels from inactivation, thus increasing their
availability. An ensuing depolarization will then
activate a greater number of channels, thereby
giving rise to a rebound burst. Such rebound
bursting is exemplified in this current-clamp
recording from a Golgi cell, which was mediated
by Cav3.1 (taken from Molineux et al., 2006)
(copyright by the National Academy of Sciences).
(B) Calcium influx via T-type channels (blue) gen-
erates a local calcium domain (orange). KCa3.1
channels that are physically associated with
T-type channels are activated by this rise in
intracellular calcium. This hyperpolarization in-
hibits the temporal summation of parallel fiber
excitatory postsynaptic potentials (EPSPs; re-
flected in a small upward spike in the current-
clamp recording, see arrow) in Purkinje neurons,
thus preventing action potential firing. Blocking
T-type channel activity with nickel (indicated by
red dot inside the channel pore) prevents calcium influx and thus reduces KCa3.1 channel activity. This allows temporal summation of parallel fiber EPSPs to
trigger action potential (AP) discharges (see bottom current-clamp trace). These recordings were taken from Engbers et al. (2012) (copyright by the National
Academy of Sciences).
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cholamine release by direct coupling of the channel activation
machinery to the vesicle release apparatus (see also Marom
et al., 2010). Whether this mechanism is specific to chromaffin
cells or perhaps also applicable to nerve terminals is unclear.
There is also increasing evidence that Cav3 calcium channels
can contribute to exocytosis, specifically catecholamine release
from chromaffin cells (Carabelli et al., 2007). They have also been
implicated in neurotransmitter release in both the retina and
olfactory bulb (Egger et al., 2003; Pan et al., 2001) (for review,
see Carbone et al., 2006) and may contribute to synaptic trans-
mission in hippocampal interneurons (Tang et al., 2011). More
recent evidence has implicated T-type calcium channels in
spontaneous synaptic release in dorsal horn synapses (Jacus
et al., 2012) and in trans-glial chemical communication between
dorsal root ganglion neurons (Rozanski et al., 2013). T-type
calcium channels are particularly well suited for supporting
low-threshold exocytosis because of their biophysical char-
acteristics (specifically their low voltage dependence of acti-
vation and inactivation), which give rise to a small window
current near resting neuronal membrane potentials (Figure 3).
This in turn allows calcium entry via these channels in response
to small voltage changes and hence activation of the release
machinery.
Like Cav2 channels, all members of the Cav3 calcium channel
family associate with the SNARE proteins syntaxin 1 and
SNAP25; however, they do so via their C terminus, rather than
the domain III-IV linker region (Weiss et al., 2012). Interestingly,
coexpression with syntaxin 1A mediates a strong hyper-
polarizing shift in half inactivation potential that is abolishedupon coexpression with SNAP25, or alternatively when syntaxin
is locked in its ‘‘open’’ conformation (Weiss et al., 2012). The
significance of modulating channel availability in this manner is
not clear, although it suggests that channels that are associated
exclusively with syntaxin 1A, rather than the full complement of
t-SNAREs, are less likely to support calcium entry and, thus,
vesicle release. Exogenous expression of Cav3.2 channels in a
chromaffin cell line induces low-threshold release, which can
be blocked by coexpressing a peptide corresponding to the
syntaxin interaction domain of the channel (Weiss et al., 2012).
This indicates that physical association of Cav3.2 with syntaxin
is of critical importance for T-type channel-mediated, low-
threshold exocytosis.
Altogether, it is remarkable that all known types of neuronal
calcium channels have been implicated in supporting secre-
tion/neurotransmitter release, with specific roles being fulfilled
by all major classes of calcium channels (i.e., fast synaptic trans-
mission for Cav2 channels, tonic and slower release by Cav1
channels, and low-threshold exocytosis by Cav3 channels).
Calcium Channels and Neuronal Firing
Both HVA and LVA channels are important regulators of neuronal
firing properties. As noted earlier, T-type channels are activated
by small membrane depolarizations. At typical neuronal resting
membrane potentials, however, a large fraction of T-type
channels are inactivated (i.e., unavailable for opening) (Coulter
et al., 1989). A transient membrane hyperpolarization can be
sufficient to recover T-type channels from their inactivated
state (Figure 3), such that an ensuing depolarization activates a
larger population of T-type channels, leading to a dramaticNeuron 82, April 2, 2014 ª2014 Elsevier Inc. 29
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causes a low-threshold calcium potential that facilitates the
activation of voltage-gated sodium channels to give rise to a
burst of action potentials (Alvin˜a et al., 2009; Destexhe et al.,
1998). This phenomenon is termed ‘‘rebound bursting’’ and is
of critical importance for the output of many different types of
neurons (Molineux et al., 2006), perhaps most notably in thala-
mocortical relay neurons and in thalamic reticular neurons
(Huguenard, 1998; Ulrich and Huguenard, 1997) (Figure 3). It
should also be noted that Cav1.3 calcium channels display a
relatively hyperpolarized range of activation (Xu and Lipscombe,
2001), and given their dendritic localization, it is possible that
these channels could act like T-type channels in regulating post-
synaptic activity.
There are other ways by which voltage-gated calcium chan-
nels can control neuronal firing frequency, and these are related
to their calcium permeability rather than their electrogenic func-
tion. In cerebellar stellate cells and perhaps other types of neu-
rons, all types of Cav3 channels are able to associate with
Kv4.2 calcium-activated potassium channels into a large macro-
molecular signaling complex that also includes K channel-inter-
acting protein 3 (KChIP3) (Anderson et al., 2010a, 2010b). This
interaction bestows calcium sensitivity onto Kv4.2 inactivation,
leading to increased Kv4.2 channel availability upon T-type
current activation and a decrease in output gain (Anderson
et al., 2010a). This phenomenon is exquisitely calcium sensitive
such that the Kv4.2/Cav3/KChIP3 complex can act as a detector
of extracellular changes in calcium concentration (Anderson
et al., 2013) and mediate adaptive changes to maintain synaptic
fidelity under conditions where extracellular calcium drops into
the submillimolar range. Similarly, Cav3 channels can physi-
cally and functionally interact with intermediate conductance
calcium-activated potassium channels (KCa3.1) in cerebellar
Purkinje neurons. Calcium entry via Cav3 channels activates
KCa3.1, which helps control temporal summation of synaptic
inputs (Engbers et al., 2012) (Figure 3). Cav3 channels also
form physical signaling complexes with large conductance cal-
cium-activated potassium (KCa1.1) channels in medial vestib-
ular neurons (Rehak et al., 2013). In these neurons calcium entry
via T-type channels helps activate KCa1.1 channels to slow firing
frequency. Along these lines, it has been reported that calcium
entry via T-type channels modulates small conductance cal-
cium-activated potassium (KCa2.1) channels in thalamic retic-
ular neurons (Cueni et al., 2008) to regulate oscillatory behavior.
This suggests that thalamic reticular neurons exhibit both
electrogenic (i.e., rebound burst) and calcium-dependent mech-
anisms by which T-type channels shape their firing properties.
Finally, the ability to regulate neuronal output via calcium-depen-
dent activation of potassium conductances is also observed
with members of the HVA calcium channel family. For example,
Cav1.2, Cav2.1, and Cav2.2 channels physically associate
with KCa1.1 channels to shape action potential repolarization
(Berkefeld and Fakler, 2008; Berkefeld et al., 2006; Mu¨ller
et al., 2010) and, in the case of chromaffin cells, pacemaking
(Vandael et al., 2012). Hence, members of all three major classes
of calcium channels are important regulators of neuronal firing
properties, by virtue of their control over calcium-sensitive
potassium channels.30 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.Calcium Channels and Gene Transcription
It is well established that increases in intracellular calcium
contribute to the initiation of gene transcription. As voltage-
gated calcium channels are a major source of calcium influx, it
is not surprising that these channels contribute to gene regula-
tion. However, they do so in an intricate and regulated manner
and in some cases independently of calcium influx. Below, we
give an overview of the role of Cava1 and Cavb subunits in this
process.
Cav1 Channels
L-type calcium channels were the first voltage-gated channels
shown to regulate gene transcription and there is an extensive
body of literature on this topic. L-type channel agonists and
antagonists were shown to, respectively, promote and inhibit
gene transcription of immediate early genes over 20 years ago
in cortical neurons (Murphy et al., 1991). CaM kinase was recog-
nized shortly thereafter as a critical signaling intermediate
between L-type channels at the cell membrane and gene tran-
scription in the nucleus (Bading et al., 1993). A brief KCl-induced
depolarization of hippocampal neurons (i.e., 1 min) promotes
translocation of calmodulin to the nucleus (Deisseroth et al.,
1998), which in turn promotes the phosphorylation and activation
of CREB (Thompson et al., 1995). Both the translocation of
calmodulin and CREB activation are perturbed by L-type
calcium channel blockers (Eickelberg et al., 1999; Wheeler
et al., 2006). Interestingly, neuronal depolarization activates
CREB gene transcription by two temporally distinct signaling
cascades. Brief depolarization (1–10 min) activates CREB
through a CaM/CaM kinase-dependent pathway, while sus-
tained depolarization (R30 min) was shown to recruit a second-
ary Ras/MAPK pathway (Wu et al., 2001).
Additional evidence for L-type channel involvement in CREB
transcription came from LTP studies in hippocampal neurons
that demonstrated that CREB transcription critically depended
on L-type calcium channel activity, with relatively little involve-
ment from AMPA and NMDA receptors (Impey et al., 1996;
Rajadhyaksha et al., 1999). This was recently confirmed with a
conditional hippocampus/neocortex Cav1.2 knockout mouse
that demonstrates an essential role of Cav1.2 in CREB signaling
during LTP and spatial learning (Moosmang et al., 2005). NMDA
receptors can however induce excitatory cell death by promot-
ing transcription of genes controlled by another transcription
factor, C/EBPb, a process opposed by L-type calcium channels
(Marshall et al., 2003). L-type channels also oppose nicotinic
signaling to CREB in ciliary ganglion neurons, although the
underlying mechanism is unclear (Chang and Berg, 2001). This
suggests that L-type channels can both promote and antagonize
aspects of gene transcription.
By expressing exogenous DHP-insensitive Cav1.2 channel
variants in hippocampal neurons, while at the same time elimi-
nating the contributions from the endogenous channels with
DHPs, Dolmetsch and colleagues were able to examine the
channel structural determinants that underlie the coupling be-
tween Cav1.2 channels and CREB activation (Dolmetsch et al.,
2001). An extended depolarization (30 min) supported CREB
gene transcription via the aforementioned Ras/MAPK pathway
whose activation was shown to depend on the IQ domain that
anchors CaM to the C terminus of the channel (Figure 4). This
Figure 4. Pathways Involved in Calcium Channel Induced Changes
in Gene Transcription
Prolonged calcium influx via Cav1 channels activates gene transcription via
Ras and MAP kinase. In addition, brief calcium activation of calmodulin (CaM)
stimulates CREB activation though direct signaling to the nucleus, or via
activation of CaM kinase that is located in close proximity of the channel. The C
terminus of Cav1.2 channels contains a transcription factor (CCAT) that can be
expressed independently of full-length calcium channels and that can trans-
locate to the nucleus. In contrast, Cav2 channel-mediated gene activation
requires the concerted action of multiple channels to give rise to a larger
calciummicrodomain that is augmented by calcium release frommitochondria
and ER (not shown). This directly activates more distantly localized CaM
kinase clusters that in turn stimulate CREB. A calmodulin-mediated activation
of NFAT has been shown to occur via calcineurin. Cavb subunits can also be
targeted to the nucleus where they appear to act as transcriptional repressors.
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and after channel opening, CaM is thought to translocate to the
nucleus to promote CREB activation (Deisseroth et al., 1998).
How exactly CaM translocates to the nucleus in response to
channel opening vis a vis the role of this interaction in CDI of
the channel is unclear. It was subsequently shown that Cav1.3
channels couple to CREBmore effectively than Cav1.2 channels
in hippocampal neurons, especially during brief periods of
neuronal activity, whereas they appear to be the exclusive driver
of CREBactivation in striatalmedium spiny neurons (Zhang et al.,
2006). In the nucleus accumbens, acute cocaine treatment acti-
vates CREB via Cav1.3 channels, but when mice are sensitized
to cocaine, Cav1.2 overrides Cav1.3-mediated CREB activity
(Giordano et al., 2010). The functional redundancy (and occa-
sionally competition) of L-type channel signaling to CREB under-
scores the importance of this process for neuronal function.
While CaM promotes CREB-mediated gene transcription in
response to prolonged neuronal activity, CaM kinase appears
to underlie a more rapid L-type channel-mediated signaling
process (Wu et al., 2001). Brief periods of channel activity result
in the translocation of CaM kinase puncta to the vicinity of the
channel, which then rapidly signal to the nucleus to activate
CREB (Wheeler et al., 2008). This phenomenon appears to be
tightly linked to the open probability of the channels rather than
a mere rise in bulk intracellular calcium, suggesting that specific
associations with L-type channels are necessary to support this
signaling process.Another twist in understanding L-type channel-mediated gene
transcription is the observation that theCav1.2 C terminus region
can translocate to the nucleus and act as a transcription factor
that was termed CCAT (calcium channel-associated transcrip-
tion) (Gomez-Ospina et al., 2006). CCATmodulates transcription
of gap junction proteins, NMDA and potassium channel sub-
units, and regulatory proteins such as kinases and chemokine
ligands (Gomez-Ospina et al., 2006). Furthermore, CCAT pro-
motes neurite outgrowth (Gomez-Ospina et al., 2013). Initially
believed to result from proteolytic cleavage of the Cav1.2
C terminus, similar to what had been reported in cardiac cells
(Hulme et al., 2006), CCAT is actually controlled by a cryptic
promoter in exon 46 of the Cav1.2 gene (Gomez-Ospina et al.,
2013). Expression analysis shows that CCAT is present in cortex,
cerebellum, and diencephalon and, more importantly, can be
expressed independently of full-length Cav1.2 mRNA (Gomez-
Ospina et al., 2013). This unexpected, nonelectrogenic function
needs to be borne in mind when considering the effects of muta-
tions in Cav1.2 channels that are linked to human disease.
Although L-type channel-mediated activation of CREB has
received perhaps the most attention, these channels also
promote activation of other transcription factors. This includes
activation of NFAT (specifically the NFATc4 isoform) in hippo-
campal neurons and is mediated by the calcium-dependent
phosphatase calcineurin (Graef et al., 1999). This process is
improved by AKAP79/150 expression in part because of
enhanced calcineurin targeting to the channels (Oliveria et al.,
2007) and also because AKAP can regulate release of calcineurin
more effectively (Li et al., 2012). Whether the CaM/IQ interaction
is involved in calcineurin/NFAT-mediated gene transcription is
unknown, although the distal C terminus of Cav1.2 is known to
bind calcineurin (Tandan et al., 2009).
Cav2 Channels
Cav2 channels also promote NFAT- and CREB-mediated gene
transcription, although the molecular underpinnings are not
well understood. One overriding theme for Cav2-mediated
gene transcription is the requirement for a global calcium rise
(reminiscent of Cav2 CDI), which is not the case for Cav1-
mediated gene transcription. For instance, Cav2.1 channels
promote expression of syntaxin 1A by a CaM kinase-, PKA-,
and MAPK-sensitive pathway (likely CREB), but not if cytosolic
calcium is buffered with EGTA (Sutton et al., 1999). Syntaxin
1A expression can also be triggered by thapsigargin, or caffeine
in the presence of u-agatoxin IVA, suggesting that although
Cav2.1 channels can promote syntaxin 1A expression, a global
rise in calcium from other sources is as effective (Sutton et al.,
1999). N-type calcium channels have been shown to promote
NFAT (NFATc1 isoform) nuclear localization in sympathetic
ganglion neurons in response to 10 Hz stimulation (Herna´ndez-
Ochoa et al., 2007). A slower 1 Hz stimulation was not
sufficient to promote NFAT translocation to nucleus, probably
because global calcium did not reach sufficiently high levels
(Herna´ndez-Ochoa et al., 2007).
The most thorough investigation into Cav2-mediated gene
transcription has been reported by Wheeler and colleagues
(2012), who showed that Cav2 channels promote CREB activa-
tion, via CaM kinase, but that this occurs much more slowly
compared with L-type calcium channels and that this processNeuron 82, April 2, 2014 ª2014 Elsevier Inc. 31
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et al., 2012). This group also showed that Cav2 signaling to
CREB can be interrupted by calcium chelation and that effi-
ciency of Cav2/CREB signaling is intimately tied tomitochondrial
and ER calcium buffering (Wheeler et al., 2012). Although we are
only beginning to understandCav2-mediated gene transcription,
it appears that global calcium elevation from vigorous neuronal
activity, such as trains of action potentials, is required for Cav2
channel-mediated CREB activation.
Cavb Subunits
Cavb3/4 subunits have also emerged as transcriptional regula-
tors, independently of their abilities to regulate calcium influx
via the Cava1 subunit. Cavb3was recently identified as a binding
partner for a novel isoform of the transcription factor Pax6
(Zhang et al., 2010). The Pax6(S) isoform is transcriptionally
active, but its function is suppressed by Cavb3 in the nucleus
(Zhang et al., 2010). The physiological relevance of this inter-
action is not yet known, but it is suspected to be important early
in embryonic development.
The Cavb4c splice isoform was first identified as a transcrip-
tional regulator after yeast two-hybrid assays from chicken brain
and cochlea, and later human vestibular neurons (Xu et al.,
2011), and shows a strong interaction with the gene silencing
protein CHCB2/HP1g (Hibino et al., 2003). Coexpression of
CHCB2/HP1g recruits Cavb4c to the nucleus, leading to disrup-
tion of CHCB2/HP1g-mediated gene silencing (Hibino et al.,
2003). Another isoform, Cavb4b, is found in the nucleus of cere-
bellar granule and Purkinje cells and is exported from the nucleus
following calcium influx or neuronal excitation (Subramanyam
et al., 2009). On the other hand, a recent study by Tadmouri
and colleagues (2012) in hippocampal neurons found that
Cavb4 is imported to the nucleus in an activity-dependent
manner alongside a regulatory subunit of PP2A phosphatase.
Once in the nucleus, association of Cavb4/PP2A with HP1g
and the thyroid hormone receptor a (aTH) leads to the repression
of thyroid hormone production (Tadmouri et al., 2012). This asso-
ciation of Cavb4 and PP2A is ablated in a prematurely truncated
Cavb4 isoform that has been associated with juvenile myclonic
epilepsy (Tadmouri et al., 2012). Interestingly, the thyroid hor-
mone derivative thyroxine exacerbates absence seizures in juve-
nile myclonic epileptic patients (Obeid et al., 1996); altogether
suggesting that Cavb4 can suppress seizure activity by downre-
gulating thyroid hormone levels. This highlights an example in
which dysfunction in an ancillary calcium channel subunit can
affect human disease independently of calcium channel func-
tion, per se.
From the data available to date, it appears that Cavb subunits
act as repressors of gene transcription, in contrast with the roles
of various calcium channel a1 subunits that tend to promote
gene activation by supporting a rise in intracellular calcium.
Calcium Channel Knockouts and Pathophysiology
A number of knockout mouse lines that lack specific calcium
channel subunits have been constructed and their behavioral
phenotypes analyzed. Moreover, a number of genetic abnormal-
ities in calcium channels have been identified in both rodents and
humans and have revealed important insights into the roles of
these channels in both physiology and pathophysiology.32 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.Cav1 Family
Mice lacking the skeletal muscle Cav1.1 isoform die at birth due
to asphyxiation, as Cav1.1 null pups cannot contract their dia-
phragms (Tanabe et al., 1988). This severe phenotype under-
scores the importance of the Cav1.1 channel for skeletal muscle
function and the fact that its highly specific role in excitation
contraction coupling cannot be compensated by other calcium
channels subtypes. In humans, mutations in the Cav1.1 channel
have been linked to hypokalemic periodic paralysis, a transient
form of paralysis that is triggered by low serum potassium and
characterized by interepisode muscle weakness (Fouad et al.,
1997; Pta´cek et al., 1994). These mutations are typically local-
ized to the voltage sensor regions in domains II, III, or IV (Fouad
et al., 1997; Hirano et al., 2011) and appear to alter the voltage
dependence of activation of the channels (Morrill et al., 1998;
Morrill and Cannon, 1999), which in turn affects excitation
contraction coupling and hence muscle function. A recently
developed mouse model of hypokalemic periodic paralysis
carrying an R528Hmutation in the domain II voltage sensor reca-
pitulates the human disease phenotype and reveals an abnormal
gating pore current that appears to lie at the root of skeletal
muscle dysfunction for this mutant channel (Wu et al., 2012)
and that was first suggested by Sokolov and colleagues (Soko-
lov et al., 2007).
Cav1.2 null mice die in utero at day 14.5 post coitum, as this
calcium channel subtype is critical for cardiac muscle contrac-
tion (Seisenberger et al., 2000). It is not clear to what extent brain
development is also altered in these animals. This issue has been
addressed with a conditional knockout mouse that lacks Cav1.2
in both hippocampus and cortex. This mouse shows impairment
of spatial memory (White et al., 2008) and produces anxiety-like
behavior (Lee et al., 2012). Interestingly, Cav1.2 conditional
knockouts do not learn from fearful stimuli, a behavior attributed
to L-type channel function in the amygdala (Jeon et al., 2010;
Langwieser et al., 2010).
Mutations in the human CACNA1C gene have been linked to
Timothy syndrome, a debilitating condition that includes mental
retardation, lethal cardiac arrhythmias, various developmental
abnormalities, and autism (Splawski et al., 2004, 2005). This is
due to mutations at the beginning of the domain I-II linker region
that interfere with both VDI and CDI (Barrett and Tsien, 2008;
Depil et al., 2011) and is consistent with the role of this linker
as a possible inactivation particle as outlined earlier in this
Review. The autism phenotype associated with Timothy syn-
drome has been successfully recapitulated in a mouse model
(Bader et al., 2011). Furthermore, isolation of pluripotent stem
cells from Timothy syndrome patients has been used to examine
the effect of these mutations on neural development (Krey et al.,
2013; Pasxca et al., 2011). These authors found that mutant
channels from Timothy syndrome patients produce activity-
dependent retraction of neuronal processes via a RhoA pathway,
thus suggesting that Cav1.2 channels are critical for proper
neuronal circuit formation that may be compromised in autistic
patients. The role of Cacv1.2 channels in mental health is further
supported by findings that SNPs located inCACNA1C are linked
to development of other psychiatric disorders such as bipolar
disorder, Schizophrenia, and depression (Dao et al., 2010; Green
et al., 2010; He et al., 2014; Strohmaier et al., 2013) (for review,
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patients with the noncoding CACNA1C risk allele Rs1006737
indicate altered amygdala function (Tesli et al., 2013), which
fits with the phenotype of the Cav1.2 conditional KO mouse.
Mice deficient for Cav1.3 are deaf (Platzer et al., 2000), as this
channel subtype is critical for auditory hair cell synaptic trans-
mission. These mice also show abnormal auditory brain stem
development (Hirtz et al., 2011), perhaps due to lack of auditory
inputs. Independently of compromised hearing, these animals
exhibit reduced immobility in forced swimming tests, suggesting
that they are somewhat resistant to depression and implicating
these channels in hippocampal function (Busquet et al., 2010).
Cav1.3 channels expressed in the ventral tegmental area have
been linked to the development of cocaine-induced long-term
behavioral changes (Schierberl et al., 2011, 2012). In the nucleus
accumbens, cocaine appears to activate CREB via Cav1.3 chan-
nels, which in turn gives rise to locomotor sensitization (Giordano
et al., 2010). Interestingly, in animals that are pre-exposed to
cocaine, there is switch from Cav1.3 to Cav1.2 channels that
ablates the CREB activation. These data indicate an important
role for Cav1.3 channels in neurological responses to psychoac-
tive drugs and underscore the importance of L-type channels in
gene regulation as discussed earlier. It is tempting to speculate
that mutations in Cav1.3 channels in the human population could
affect susceptibility to substances such as cocaine. A clear link
between Cav1.3 channels and human disease has been estab-
lished for two families with familial deafness. These individuals
carry a glycine insertion mutation near the Cav1.3 pore that
results in nonconducting channels (Baig et al., 2011). Affected
individuals also display sinoatrial node dysfunction, consistent
with the importance of this channel in cardiovascular function;
however, no information is available about the neurological
phenotype of these patients. It is also worth noting that Cav1.3
channel expression is upregulated in brains of early-stage
Parkinson’s patients (Hurley et al., 2013); however, it is not clear
if this is coincident with disease or an epiphenomenon. Nonethe-
less, Cav1.3 calcium channel blockers have been suggested as
a potential therapeutic for Parkinson’s disease (Kang et al.,
2012), in part based on earlier observations showing that
Cav1.3 channels regulate the pacemaking of dopaminergic
neurons in the substantia nigra in an age-dependent manner,
with older neurons increasingly relying on this channel type
(Chan et al., 2007). Interestingly, blocking Cav1.3 channels was
sufficient to ‘‘reset’’ neurons to their juvenile state. Altogether,
data from mice and humans confirm a critical role of Cav1.3
channels in audition but also suggest an involvement of this
channel type in other neurophysiological functions, in particular
in the dopaminergic system.
Mice lacking Cav1.4 are blind due to the importance of this
channel in rod photoreceptor synaptic transmission (Chang
et al., 2006; Lodha et al., 2010). These mice also show defects
in ribbon synapse structure (Liu et al., 2013). Interestingly, mice
deficient in CaBP4 have a phenotype that is qualitatively similar
to those of Cav1.4 null mice (Haeseleer et al., 2004), consistent
with the notion that CaBP4 is an essential functional regulator
of Cav1.4 channels. Many different mutations in the CACNA1F
gene that encodes Cav1.4 have been identified in human
patients with congenital stationary night blindness-2 (for review,see Lodha et al., 2012). In some cases, these mutations lead to a
loss of functional protein (Bech-Hansen et al., 1998), in others
the mutations result in gain of function (Hemara-Wahanui et al.,
2005), and yet another set of mutations causes a clinical pheno-
type, without any discernible effects on the biophysical proper-
ties of the channel (McRory et al., 2004). How such a variety of
Cav1.4 mutations produce essentially the same clinical pheno-
type is not clear; however, insights may be gleaned from trans-
genic mouse models that recapitulate human congenital night
blindness-2 (Knoflach et al., 2013).
Cav2 Family
Mice with a deletion of the gene encoding Cav2.1 display
severe ataxia and develop absence seizures before they die
approximately 4 weeks postnatal (Jun et al., 1999). The ataxic
phenotype observed with these animals is consistent with the
importance of P-/Q-type channels in cerebellar physiology. In
hippocampal neurons and motor neuron endplates, there is
functional compensation by Cav2.2 and Cav2.3 channels that
allows for continued synaptic transmission (Jun et al., 1999;
Urbano et al., 2003), although the notion that these animals
experience seizures indicates that this compensation is in-
complete. Several mouse lines with mutations in Cav2.1 chan-
nels have been identified, including ‘‘leaner,’’ ‘‘tottering,’’ and
‘‘rocker’’ mice, which have overlapping phenotypes that include
ataxia and absence seizures (for review, see Pietrobon, 2002), in
many ways similar to those observed with knockout of the entire
gene.Mice in which Cav2.1 channels are selectively knocked out
in Purkinje cells (postnatal) do not initially present with the full
spectrum of neurological dysfunctions but instead develop
them during adulthood (Mark et al., 2011). This suggests an
important role of these channels in early development.
In humans, alterations of Cav2.1 channels produce a range of
phenotypes. Gain-of-function mutations in the CACNA1A gene
have been linked to familial hemiplegic migraine (Tottene et al.,
2009), with mutation loci determining a wide range of disease
severity (Pietrobon and Moskowitz, 2013). Two representative
mutations have been incorporated into mouse models and reca-
pitulate remarkably well the human disease phenotype and
severity (van den Maagdenberg et al., 2004, 2010). Of particular
note is a recent study that showed that the pathophysiological
effects of the S218Lmutation can be offset by tert-butyl dihydro-
quinone, a compound that counteracts the gain-of-function
effects of this mutation on channel gating (Inagaki et al., 2014).
In contrast, loss-of-function mutations in Cav2.1 including
some that lead to truncations, frame shifts, and aberrant splicing
(Kipfer et al., 2013) have been identified in patients with episodic
ataxia-type 2 (Pietrobon, 2010). Several of these loss-of-function
mutations result in dominant-negative effects on normal Cav2.1
channels (Jeng et al., 2006) through a direct protein degradation
mechanism (Mezghrani et al., 2008) that is dependent on an 11
amino acid stretch in the channel N terminus (Page et al.,
2010). One episodic ataxia patient bearing a Cav2.1 mutation
that causes a premature truncation of the channel protein also
experienced seizures (Jouvenceau et al., 2001). This is reflective
of what is observed with Cav2.1-deficient mice and is in line with
more recent reports that identified Cav2.1 channels as a risk
allele for seizures (albeit via complex interactions with other
genes) (Klassen et al., 2011). Overall, it appears that mutationsNeuron 82, April 2, 2014 ª2014 Elsevier Inc. 33
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episodic ataxia and/or absence seizures, while gain-of-function
mutations lead to spreading cortical depression and migraine.
A different from of cerebellar ataxia (spinal cerebellar ataxia
type 6) is caused by polyglutamine expansions in the Cav2.1 C
terminus (Jodice et al., 1997). There are conflicting reports on
the functional effects of these expansions in various heterolo-
gous systems. In Purkinje cells, the channels appear to function
normally (Saegusa et al., 2007) and yet in a mouse model, they
seem to give rise to progressive neuronal dysfunction (Watase
et al., 2008). Neuronal defects can occur by mechanisms that
are similar to polyglutamine expansion disorders (i.e., through
the formation of aggregates) but perhaps require specific biolog-
ical conditions not currently understood.
In contrast with Cav2.1, mice lacking the other major presyn-
aptic channel Cav2.2 show a much milder phenotype. They are
hyposensitive to inflammatory and neuropathic pain (Hata-
keyama et al., 2001; Kim et al., 2001a; Saegusa et al., 2001),
which fits with the importance of these channels in synaptic
transmission between sensory fibers and dorsal horn neurons.
These mice also show deficits for sympathetic control of heart
rate and blood pressure (Mori et al., 2002) and are hyperactive
(Beuckmann et al., 2003). Most interestingly, these animals
exhibit reduced voluntary ethanol intake and reduced hypnotic
response to alcohol (Newton et al., 2004). Cav2.3 null mice
also have a mild phenotype that includes hyposensitivity to
pain (Saegusa et al., 2002) and resistance to chemically induced
seizures (Weiergra¨ber et al., 2007). We are not aware of any
mutations in Cav2.2 or Cav2.3 in humans and this is likely
because mutations in these channels generate only mild, medi-
cally undetected phenotypes.
Cav3 Family
Cav3.1 null mice show bradycardia due to slowing of sinoatrial
node pacemaking and reduced atrioventricular conduction
(Mangoni et al., 2006). Their nervous system phenotype includes
a resistance to baclofen-induced seizures (Kim et al., 2001b).
Furthermore, ablation of this channel isoform also protects
from seizures in Cav2.1 null or mutant mice such as ‘‘tottering’’
(Song et al., 2004). This fits well with the known role of T-type
channels in the thalamocortical circuitry. The key function of
Cav3 channels in thalamic neurons is underscored by the obser-
vations that targeted deletion of Cav3.1 in the thalamus results in
increased arousal and altered sleep/wake patterns (Anderson
et al., 2005) and that Cav3.3 null mice exhibit compromised sleep
spindles in thalamic reticular neurons (Astori et al., 2011).
Cav3.2 null mice show compromised coronary function due to
a permanent constriction of coronary arterioles (Chen et al.,
2003). These mice also show reduced sensitivity to noxious
pain (consistent with the expression of these channels in a
subset of afferent pain fibers), but not chronic neuropathic pain
(Choi et al., 2007). This contrasts with the potent analgesic
actions of intrathecally delivered Cav3.2 channel blockers in
neuropathic pain models, suggesting that there is compensation
from other types of (calcium) channels in the afferent fibers of
Cav3.2 null mice that maintain pain transmission. On the flip
side, mice subjected to nerve injury, colonic inflammation (Jago-
dic et al., 2008; Marger et al., 2011), or chronic diabetic condi-
tions (Jagodic et al., 2007) show increased T-type channel34 Neuron 82, April 2, 2014 ª2014 Elsevier Inc.conductance in sensory neurons, which then contributes to the
development of chronic pain. The underlying mechanisms for
this remain to be elucidated but may involve posttranslational
modification of the channels (Orestes et al., 2013). In this regard,
T-type calcium channels serve as a unique example where
disorders can be triggered by misregulation of channel expres-
sion, rather than mutations in the channels.
In humans, a number of mutations in Cav3.2 have been linked
to generalized epilepsies (Heron et al., 2004, 2007). When intro-
duced into recombinant channels, the vast majority of these
mutations have only small effects on channel biophysics and
cell surface density (Khosravani et al., 2004, 2005; Vitko et al.,
2005). However, when expressed in neurons, at least one of
these mutations (C456S) increased neuronal firing by reducing
the threshold for rebound bursting (Eckle et al., 2014). The
C456S channel mutant also enhances neurite outgrowth and
dendritic arborization (Eckle et al., 2014), possibly explaining
why some mutations appear to lack disease phenotypes in
recombinant systems. One study reported Cav3.1 polymor-
phisms in families with juvenile myoclonic epilepsy (Singh
et al., 2007), but no detailed linkage analysis was performed
and it is thus not unclear if these mutations truly segregate
with phenotype.
Finally, all three Cav3 channels have been linked to autism
spectrum disorders (Lu et al., 2012; Splawski et al., 2006). The
functional consequence of three autism mutations in the
CACNA1H gene have been examined in heterologous systems
and shown to result in reduced T-type currents (Splawski
et al., 2006). How this contributes to autism, and if interactions
with other autism risk alleles are necessary, remains to be deter-
mined.
Altogether, Cav3 channels appear to play important roles in
regulating neuronal excitability, whereas their elimination (and
inhibition) protects from hyperexcitability disorders such as
absence epilepsy and certain forms of pain.
Ancillary Calcium Channel Subunits
Several knockout mouse lines lacking ancillary calcium channels
have been generated. Mice lacking the Cavb1 subunit display a
phenotype that is similar to that of Cav1.1 knockout mice (Gregg
et al., 1996; Strube et al., 1996), as this subunit is essential for
skeletal muscle L-type calcium channel function. Along these
lines, deletion of the Cavb2 subunit produces an embryonic
lethal phenotype due to reduced expression of Cav1.2 channels
in the heart (Meissner et al., 2011; Weissgerber et al., 2006).
These are two examples in which the absence of an ancillary
subunit is directly associated with compromised function of an
interacting Cava subunit. Mice in which Cavb1 or Cavb2 deletion
is limited to the CNS are viable, allowing some insights into the
function of these subunits in the nervous system. Findings with
this region-specific Cavb2 mouse reveals malformation of the
outer plexiform layer of the retina (Ball et al., 2002), suggesting
that this subunit may be an important regulator of retinal
L-type calcium channels. Cavb3 knockout mice show improved
glucose homeostasis (Berggren et al., 2004), and increased
epinephrine release from the adrenal gland (Ohta et al., 2010).
Targeted deletion of Cavb3 subunits in neurons yields no overall
behavioral or grossmorphological phenotype but results in alter-
ations of N-type and P-/Q-type currents in superior cervical
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Cavb4 results in a phenotype termed the ‘‘lethargic mouse’’
(Burgess et al., 1997). Here, a naturally occurring mutation
produces a premature stop codon and a de facto knockout of
the subunit. This results in the development of absence seizures
and ataxia, similar to what is observed upon deletion of Cav2.1
channels, suggesting that Cavb4 could be a specific and neces-
sary component of P-/Q-type calcium channel complexes (Mich
and Horne, 2008). While there is partial functional compensation
from other Cavb subunits in these mice (Burgess et al., 1999),
this does not appear to be able to overcome the absence of
Cavb4.
Ducky 2J mice carry a mutation in the Cava2d2 subunit-
encoding gene that leads to a premature stop codon and thus
a truncated protein. These mice show severe seizure activity,
ataxia, and uncoordinated gait, as well as compromised den-
dritic arborization of their cerebellar Purkinje neurons (Barclay
et al., 2001). The Ducky 2J mouse phenotype must be consid-
ered with some reservation, however, because a truncated
Cava2d2 is still produced and, therefore, is not a bona fide
knockout animal (Brodbeck et al., 2002). Knockout of Cava2d1
is embryonic lethal to our knowledge, perhaps because this
subunit is essential for targeting multiple types of calcium chan-
nels in various tissues to the plasma membrane. However, a
recent targeted deletion of this subunit in the heart results in
reduced cardiac L-type channel amplitude and decreased
contractility (Fuller-Bicer et al., 2009). Finally, loss-of-function
mutations in mouse Cavg2 (stargazin) give rise to absence
seizures (Letts et al., 1998) and although stargazin has small
effects on Cav2.1 channel function, it is likely that the epileptic
phenotype of the mouse is related to alterations in AMPA recep-
tor expression (Payne et al., 2006; Ryu et al., 2008).
In humans, variations in coding and noncoding regions of
Cavb4 have been associated with juvenile myoclonic epilepsy
(Escayg et al., 2000). One of these mutations produces a short
C-terminal truncation in the Cavb4 protein, and its coexpression
with Cav2.1 channels results in altered gating kinetics of the
channel. As discussed earlier, the association of Cavb4 with
Ppp2r5d, a regulatory subunit of phosphatase 2A, results in
translocation of this complex to the nucleus in order to regulate
gene expression, for which this process is compromised with
truncated Cavb4 subunits (Tadmouri et al., 2012). The gene
encoding Cavb2 has been linked to bipolar disorder in the Chi-
nese Han population (Lee et al., 2011), hypertension (Lin et al.,
2011), and cardiac conduction disease (Hu et al., 2010). Finally,
a single nucleotide change in Cava2d4 has been associated with
cone dystrophy in humans (Wycisk et al., 2006). This mutation
introduces a premature stop codon that leads to truncation of
the full-length protein by about 30%. Progressive cone dystro-
phy has also been observed with Cav1.4 channel mutations
that lead to truncated channels (Jalkanen et al., 2006), suggest-
ing that the Cava2d4 mutation may result in altered Cav1.4
currents in cones, which ultimately mediates the dystrophic
phenotype.
Altogether, there is growing body of literature that reveals an
association between mutations of various calcium channel
subunits and a wide spectrum of neurological and nonneurolog-
ical diseases that range from mild to extremely severe. Below,we shall discuss some additional considerations pertaining to
the mechanisms by which mutations in these subunits generate
the observed phenotypes.
Additional Considerations and Caveats
Information gained from knockout mouse models and genetic
abnormalities in humans can provide important insights into
the physiological roles and functions of calcium channels and
their ancillary subunits. For some calcium channelopathies,
there is a clear understanding of how mutations perturb channel
function at the molecular level to give rise to a disease pheno-
type. For example, Cav1.2 Timothy syndrome mutations can
disable the putative inactivation gate hinge of the channel
(Barrett and Tsien, 2008; Depil et al., 2011). This then slows
both calcium and voltage-dependent inactivation, leading to
persistent L-type currents that alter the cardiac action potential
and produce tonic calcium entry into neurons. The latter process
can then affect neuronal excitability and augment calcium-
dependent gene transcription. Along these lines, a mutation
in the domain IIS6 region of Cav1.4 linked to night blindness
dramatically slows inactivation, while concomitantly enhancing
activation gating of the channel. The net functional result is
an altered window current that affects tonic glutamate release
in the dark and ultimately vision (Hemara-Wahanui et al.,
2005). In other words, some calcium channel mutations create
compelling links between channel biophysics and physiological
output.
In other cases, however, channel biophysics do not equate
well with the physiological outcome. Several Cav3.2 absence
epilepsy mutations, for instance, have mild biophysical abnor-
malities yet somehow impart profound changes in neuronal
excitability, especially in thalamic neurons. While these mutant
channels should increase seizure activity in neurons, it is unclear
how they do this at the molecular level. Some of the mutations
may not affect Cav3.2 channel function at all but instead modu-
late interactions with other regulatory proteins or ion channels,
such as the calcium-activated potassium channel family, which
secondarily affect neuronal firing (Anderson et al., 2010a; Engb-
ers et al., 2012). Another potential explanation is that some
Cav3.2 mutations are only functionally relevant when present in
a specific splice isoform (Powell et al., 2009), and thus choosing
the correct channel backbone for phenotypic evaluation is crit-
ical. This idea may also explain why gain-of-function mutations
in Cav3.2, which are linked to absence seizures, do not produce
hyperexcitability in other nervous system regions, such as
afferent pain fibers. Splice isoform-specific unmasking of mutant
phenotypes has also been demonstrated for Cav2.1 (Adams
et al., 2009) and may very well apply to other calcium channels
subunits. Finally, it is important to reiterate that mutations in
calcium channels and their ancillary subunits that are linked to
gene transcription may result in complex changes in protein
expression that ultimately determine the disease phenotype.
This is true for mouse lines such as ‘‘lethargic’’ or ‘‘tottering’’
where mutations in ancillary subunits somehow result in
increased thalamic T-type currents and absence seizures
(Zhang et al., 2002). This cautionary example, along with the
possibility of compensatory changes in channel expression, is
a reminder that any observed phenotype may not be directly
related to the gene in question.Neuron 82, April 2, 2014 ª2014 Elsevier Inc. 35
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Since the discovery of calcium currents nearly half a century ago,
tremendous progress has been made in understanding the
structure, function, and physiology of voltage-gated calcium
channels. Since the groundbreaking work of Katz and Miledi
(1967), Hagiwara and Nakajima (1966), and Reuter (1967), there
have been many memorable milestones. This includes the iden-
tification of multiple native calcium channel subtypes (Nowycky
et al., 1985), evidence that HVA calcium channels are multimeric
protein complexes (Curtis and Catterall, 1984), the cloning and
expression of the first calcium channel gene (Tanabe et al.,
1987, 1988), and the generation of various calcium channel
knockout mouse lines and the crystallization of the Cavb subunit
(Chen et al., 2004; Opatowsky et al., 2004; Van Petegem et al.,
2004). We now have an in-depth understanding of calcium chan-
nel pharmacology (for review, see Doering and Zamponi, 2005),
their regulation by second messengers such as G proteins and
protein kinases (Fuller et al., 2010; Tedford and Zamponi,
2006), and, as discussed here, their roles in neuronal physiology
and pathophysiology. Futuremilestonesmay include the crystal-
lization of a Cava1 subunit (perhaps Cav3, as it does not asso-
ciate with ancillary subunits), in-depth analysis of splice varia-
tions, and the roles of these variants in specific areas of
the nervous system. Future research should also bring a better
understanding of mechanisms underlying calcium channel
dysregulation during disease, with perhaps a focus on posttrans-
lational modifications and alterations in channel trafficking.
Generation of novel mouse models that allow inducible and
region-specific changes in calcium channel expression would
also elevate our understanding of calcium channel physiology
in the central and peripheral nervous systems.ACKNOWLEDGMENTS
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